Context Therapeutics Inc.·4

Nov 1, 4:31 PM ET

Minai-Azary Jennifer Lynn 4

4 · Context Therapeutics Inc. · Filed Nov 1, 2021

Insider Transaction Report

Form 4
Period: 2021-11-01
Minai-Azary Jennifer Lynn
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-11-01+52,75352,753 total
    Exercise: $5.59Exp: 2031-11-01Common Stock (52,753 underlying)
Footnotes (1)
  • [F1]The stock option vests each month (1/36 each month) from the date of the grant, November 1, 2021

Documents

1 file
  • 4
    wf-form4_163579861906118.xmlPrimary

    FORM 4